This is a dataset from a phase III, randomised, double-blind, placebo and active product controlled, multicentre clinical trial with three parallel treatment arms to compare effects on ADHD and ADD behaviour between Pycnogenol®, MPH (Medikinet® Retard) and placebo, using the ADHDRating Scale (ADHD-RS/ARS) as a primary outcome measure. Evaluations were performed in weeks 5 and 10, as compared to baseline. Two visits with similar evaluations were conducted: at baseline and after 10 weeks. Next to baseline and final evaluations, an extra evaluation of behaviour and physical symptoms was conducted in week 5 by means of questionnaires. The trial population will consists of ADHD and ADD patients recruited at the University Hospitals of Antwerp (...
(200 mg) and Ginkgo biloba extract (50 mg) (AD-FX; CV Technologies, Edmonton, Alta.) was tested for ...
Background: The prevalence rate of attention-deficit/hyperactivity disorder (ADHD) within Western cu...
BACKGROUND: The prevalence rate of attention-deficit/hyperactivity disorder (ADHD) within Western cu...
Objectives: Determine the effect of French Maritime Pine Bark Extract (PBE; Pycnogenol®) on Attentio...
Objectives: To evaluate the effect of French Maritime Pine Bark Extract (PBE; Pycnogenol®) on immune...
Background: Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity d...
Abstract Background Methylphenidate (MPH), the first choice medication for attention-deficit hyperac...
Background: Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity d...
INTRODUCTION: This study investigated the effects of a marine oil extract (PCSO-524®) on inattention...
Introduction: This study investigated the effects of a marine oil extract (PCSO-524®) on inattention...
Background: Methylphenidate improves clinical symptoms and brain activity in attention deficit hyper...
Overview: Complementary and Alternative Medicines (CAMs) are frequently given to children and adoles...
Overview: Complementary and Alternative Medicines (CAMs) are frequently given to children and adoles...
Attention deficit hyperactivity disorder (ADHD) is an increasingly prevalent behavioural disorder ch...
Attention deficit hyperactivity disorder (ADHD) is an increasingly prevalent behavioural disorder ch...
(200 mg) and Ginkgo biloba extract (50 mg) (AD-FX; CV Technologies, Edmonton, Alta.) was tested for ...
Background: The prevalence rate of attention-deficit/hyperactivity disorder (ADHD) within Western cu...
BACKGROUND: The prevalence rate of attention-deficit/hyperactivity disorder (ADHD) within Western cu...
Objectives: Determine the effect of French Maritime Pine Bark Extract (PBE; Pycnogenol®) on Attentio...
Objectives: To evaluate the effect of French Maritime Pine Bark Extract (PBE; Pycnogenol®) on immune...
Background: Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity d...
Abstract Background Methylphenidate (MPH), the first choice medication for attention-deficit hyperac...
Background: Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity d...
INTRODUCTION: This study investigated the effects of a marine oil extract (PCSO-524®) on inattention...
Introduction: This study investigated the effects of a marine oil extract (PCSO-524®) on inattention...
Background: Methylphenidate improves clinical symptoms and brain activity in attention deficit hyper...
Overview: Complementary and Alternative Medicines (CAMs) are frequently given to children and adoles...
Overview: Complementary and Alternative Medicines (CAMs) are frequently given to children and adoles...
Attention deficit hyperactivity disorder (ADHD) is an increasingly prevalent behavioural disorder ch...
Attention deficit hyperactivity disorder (ADHD) is an increasingly prevalent behavioural disorder ch...
(200 mg) and Ginkgo biloba extract (50 mg) (AD-FX; CV Technologies, Edmonton, Alta.) was tested for ...
Background: The prevalence rate of attention-deficit/hyperactivity disorder (ADHD) within Western cu...
BACKGROUND: The prevalence rate of attention-deficit/hyperactivity disorder (ADHD) within Western cu...